Tiziana Life Sciences PLC (LON:TILS)’s stock price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $41.28 and traded as low as $31.00. Tiziana Life Sciences shares last traded at $34.00, with a volume of 15,005 shares changing hands.
Separately, Shore Capital reaffirmed a “house stock” rating on shares of Tiziana Life Sciences in a report on Friday, November 1st.
The company has a current ratio of 0.32, a quick ratio of 0.31 and a debt-to-equity ratio of 59.12. The company has a market capitalization of $46.46 million and a PE ratio of -7.39. The stock’s 50-day moving average is GBX 41.14 and its two-hundred day moving average is GBX 45.73.
About Tiziana Life Sciences (LON:TILS)
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as non-alcoholic steatohepatitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
Featured Article: Current Ratio
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.